Company Filing History:
14 out of 363 
5 out of 2,078 
1 out of 377 Years Active: 2003-2017
Title: Hui Cai: Innovator in Pharmaceutical Compounds
Introduction
Hui Cai, based in San Diego, CA, is a prolific inventor with an impressive portfolio of 21 patents. His work primarily focuses on developing novel pharmaceutical compounds that aim to address various health conditions by modulating receptor activity.
Latest Patents
Among his latest inventions are two significant patents related to histamine H4 receptor modulators. These include diamino-pyridine, pyrimidine, and pyrazine compounds designed for use as H-receptor modulators. These innovative compounds have the potential to be included in pharmaceutical compositions and methods for the treatment of various disease states, disorders, and conditions mediated by H-receptor activity, such as allergies, asthma, autoimmune diseases, and pruritus.
Career Highlights
Hui Cai has contributed his expertise at notable companies in the pharmaceutical industry, including Ortho-McNeil Pharmaceutical Corporation and Janssen Pharmaceutica NV. His work in these organizations has significantly advanced the field of drug development, particularly concerning receptor modulation and its therapeutic applications.
Collaborations
Throughout his career, Hui has worked alongside esteemed colleagues such as Jianmei Wei and James Patrick Edwards. These collaborations have fostered a rich environment for innovation and has allowed the development of groundbreaking pharmaceutical solutions.
Conclusion
Hui Cai exemplifies the spirit of innovation in the pharmaceutical domain. With his extensive patent portfolio and collaborative efforts, he continues to pave the way for new treatments that can improve the quality of life for individuals suffering from various medical conditions. His dedicated work is a testament to the vital role inventors play in advancing healthcare through innovative solutions.